Guidance and quality standards Awaiting development
Showing 1 to 1 of 1
Title | Type |
---|---|
Favezelimab–pembrolizumab for previously treated PD-L1-positive metastatic colorectal cancer [ID6278] | Technology appraisal guidance |
Title | Type |
---|---|
Favezelimab–pembrolizumab for previously treated PD-L1-positive metastatic colorectal cancer [ID6278] | Technology appraisal guidance |